ClinicalTrials.Veeva

Menu

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER)

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Enrolling

Conditions

Emergencies

Treatments

Device: Babies in the Owlet monitor group

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06565390
300013146
OSP 000545308 (Other Grant/Funding Number)

Details and patient eligibility

About

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Full description

To determine if among infants being discharged from the neonatal intensive care unit (NICU) without a cardiorespiratory monitor or respiratory support, remote patient monitoring using an Owlet OSS 3.0 pulse oximeter (Owlet, Lehi, UT) decreases emergency room visits and high-acuity rehospitalizations after discharge compared with routine care.

Infants being discharged from the neonatal intensive care unit (NICU) without a cardiorespiratory monitor or respiratory support are eligible for inclusion.

The Investigators will provide remote patient monitoring using an Owlet OSS 3.0 pulse oximeter to infants in the intervention group for a 6 month period. The Investigators will collect monthly outcome measures from caregivers of all infants.

Enrollment

700 estimated patients

Sex

All

Ages

22 weeks to 6 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants being discharged from the NICU
  • Off all respiratory support (oxygen, CPAP, ventilator) before discharge home
  • Gestational age ≥ 22 0/7 weeks' gestation at birth
  • Parents/legal guardians have provided consent for enrollment

Exclusion criteria

  • a major malformation, a neuromuscular condition that affects respiration or causes apnea, complex congenital heart disease and hemodynamically significant shunts, or terminal illness or decision to withhold or limit support.
  • Infants being discharged from the neonatal intensive care unit (NICU) with a cardiorespiratory monitor or respiratory support are not eligible for inclusion.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

700 participants in 2 patient groups

Babies in the Owlet monitor group
Experimental group
Description:
The Owlet group will be given an Owlet OSS 3.0 monitor to wear when sleeping. The Owlet alarms if the baby has a very low heart rate or very low oxygen levels. In addition, caregivers in the Owlet group with a smart phone and Wi-Fi access will be able to use an application to monitor the baby's vital signs and sleep state. Will complete a survey or questionnaire every month until 6 months after discharge.
Treatment:
Device: Babies in the Owlet monitor group
Babies in the Usual Care Group
No Intervention group
Description:
The usual care group will not be given an Owlet vital sign monitor. Will complete a survey or questionnaire every month until 6 months after discharge.

Trial contacts and locations

1

Loading...

Central trial contact

Rachel Benz, MSN; Kimberly Armstead, BS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems